Multiple Research Results from Innovent’s General Biomedicine Pipeline Showcased at 2025 ACR Annual Meeting

SAN FRANCISCO and SUZHOU, China, Nov. 4, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops,…